Original release date: May 3, 2019
Access to this course expires on: February 23, 2022, at 11:59 PM Pacific Time
Early diagnosis of a myriad of benign and malignant diseases (presenting as swellings) affecting the head and neck provides the best chance for successful treatment. Fine Needle Aspiration (FNA) is an expedient and cost-effective method to sample these masses and is the primary biopsy method for thyroid and salivary glands and a useful approach to evaluate lymph nodes. The majority of practicing pathologists have not completed formal fellowship training in cytopathology and do not have a diagnostic paradigm for these relatively common specimen types. This course is intended to help close the gap by building a strong foundation in head and neck cytopathology and familiarizing attendees with the common diagnostic challenges encountered when evaluating FNA specimens from the thyroid, salivary glands and lymph nodes. The outcome should be an increase in the number of definitive diagnoses, reduction in equivocal diagnoses, and mitigation of repeat FNA or subsequent invasive procedures.
The target audience is general pathologists with an interest in cytopathology, pathology residents and fellows, surgical pathology fellows and cytopathology fellows.
Learning Objectives Upon completion of this educational activity, learners will be able to:
- Become competent in diagnosis of some of the most common lesions in head and neck cytopathology
- Establish a systematic approach to some of the diagnostic dilemmas in head and neck cytopathology
- Understand the Bethesda System for Reporting Thyroid Cytopathology and the Milan System for Reporting Salivary Gland Cytopathology
- Learn how to triage FNA specimens from squamous lesions of the head and neck and how to test for HPV in this setting
- Cultivate pathologists’ confidence to avoid equivocation, reporting delays, and repeat or additional diagnostic procedures
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25
AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12.25 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Elham Khanafshar, MD, MS, Britt-Marie Ljung, MD, Sarah M. Calkins, MD, Annemieke van Zante, MD
The following IM Coordinators reported no relevant financial relationships: David B. Kaminsky, MD, FIAC and Raja R. Seethala, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking here.
Buy the entire Head and Neck Cytopathology course and get a great discount!
Not A Member? Click Here